publication venue for
- Can we manage gut microbiome imbalances in patients with bipolar disorder with pharmacotherapy?. 24:1957-1961. 2023
- The pharmacotherapeutic management of premenstrual dysphoric disorder. 24:145-151. 2023
- Azacitidine and its role in the upfront treatment of acute myeloid leukemia. 23:873-884. 2022
- Pharmacotherapeutic management of asthma in pregnancy and the effect of sex hormones. 22:339-349. 2021
- Quizartinib for the treatment of acute myeloid leukemia. 21:2077-2090. 2020
- An evaluation of roflumilast and PDE4 inhibitors with a focus on the treatment of asthma. 20:609-620. 2019
- Systemic treatments for metastatic urothelial carcinoma. 20:201-208. 2019
- Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke. 19:1597-1602. 2018
- Initial and long-term treatment of deep venous thrombosis: recent clinical trials and their impact on patient management. 14:385-396. 2013
- Montelukast for the treatment of asthma in the adult population. 12:2119-2128. 2011
- Review of the use of mirtazapine in the treatment of depression. 12:1623-1632. 2011
- Lipid modification in the elderly using the combination of a statin and a cholesterol absorption inhibitor. 12:675-678. 2011
- Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data. 9:2707-2715. 2008
- Latest medical treatment strategies for venous thromboembolism. 8:1221-1233. 2007
- Candesartan for the management of heart failure: more than an alternative. 7:1945-1956. 2006
- Treating osteoporosis: economic aspects of bisphosphonate therapy. 7:1457-1467. 2006
- Ramipril in the treatment of vascular diseases. 6:1911-1919. 2005
- Bivalirudin: a review. 6:1349-1371. 2005
- An evaluation of paroxetine in generalised social anxiety disorder. 6:819-830. 2005
- Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy. 5:1373-1384. 2004
- Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness. 5:493-503. 2004
- Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness. 5:493-503. 2004
- Review of enoxaparin and its clinical applications in venous and arterial thromboembolism. 3:575-598. 2002